Molecular and Cellular Biology, June 2005, p. 5292-5305, Vol. 25, No. 12
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.12.5292-5305.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Tanya T. Paull,4
John C. Lucchesi,3
Kum Kum Khanna,5
Thomas Ludwig,2 and
Tej K. Pandita1*
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63108,1 College of Physicians and Surgeons, Columbia University, New York, New York 10032,2 Department of Biology, Emory University, Atlanta, Georgia 30322,3 University of Texas at Austin, Austin, Texas 78712,4 Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia5
Received 22 October 2004/ Returned for modification 13 December 2004/ Accepted 21 March 2005
| ABSTRACT |
|---|
|
|
|---|
hMOF or by RNA interference-mediated hMOF knockdown, resulted in decreased ATM autophosphorylation, ATM kinase activity, and the phosphorylation of downstream effectors of ATM and DNA repair while increasing cell killing. In addition, decreased hMOF activity was associated with loss of the cell cycle checkpoint response to DNA double-strand breaks. The overexpression of wild-type hMOF yielded the opposite results, i.e., a modest increase in cell survival and enhanced DNA repair after IR exposure. These results suggest that hMOF influences the function of ATM. | INTRODUCTION |
|---|
|
|
|---|
ATM (ataxia-telangiectasia-mutated protein) is crucial for the initiation of signaling pathways in mammalian cells following exposure to ionizing radiation (IR) and other DNA-damaging agents (36, 46), and cells deficient in ATM function also have defective telomere chromatin (47). Bakkenist and Kastan (4) have suggested that chromatin structural perturbations induced by DNA double-strand breaks (DSBs) serve as a trigger for ATM activation. Recent studies indicate that the MRN (Mre11, Rad50, and Nbs1) complex as well as TRF2 either influences activation of ATM (9, 29, 52) or serves as a modulator/amplifier of ATM activity (17, 23). Our studies on DNA and chromosome damage after treatment with IR suggested that cells deficient in ATM function were less efficient in blocking the conversion of DNA damage into chromosome damage (33, 38, 40), possibly indicating an inherent chromatin alteration (16, 39). ATM has been reported to regulate the function of some histone-modifying factors (22, 27). In this report, we have identified hMOF as an ATM-interacting protein and have provided evidence that functional hMOF participates in the activation of ATM in response to DNA damage. hMOF is the human ortholog of Drosophila MOF, a histone acetyltransferase that modifies the X-chromosome chromatin in males in order to achieve dosage compensation (15).
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
hMOF) were cloned into the mammalian expression vector pIND(SP1)/Neo (Invitrogen, Carlsbad, CA) as described previously (18, 45). Mutant forms of hMOF were created by using a PCR approach with appropriate primer pair combinations. ATM
LZ was generated as described previously (10). The wild or mutant forms tagged to GFP, HA, or Flag were cloned into the pIND(SP1)/Neo vector. The final constructs were verified by DNA sequencing. An adenoviral construct expressing hMOF (Ad.hMOF) was constructed as described previously (44). hMOF small interfering RNA (siRNA) and control Luc siRNA were obtained from Dharmacone Research (Lafayette, CO). We also used the hMOF siRNA vector pRNA-U6.1/Neo (GeneScript). Western analysis, immunoprecipitation, HAT, and ATM kinase assays. Cell lysates were prepared according to the previously described procedure (41). Polyclonal hMOF antibody raised in rabbit has been described previously (34). Immunoblotting and detections for hMOF and ATM were done according to a previously described procedure (41, 45). For immunoprecipitation (IP), cells were broken in lysis buffer as described previously (41). Lysates were precleaned with purified immunoglobulin G and protein A/G beads. Proteins were immunoprecipitated with specific antibodies, and immunoprecipitants were washed with lysis buffer as described previously (41). An ATM kinase assay was performed as described previously (41). A histone acetyltransferase (HAT) assay was performed according to the manufacturer's instructions (Upstate Biotechnology).
Assay for ionizing radiation sensitivity. Cells were plated in 35-mm dishes. The cell count was determined using a Coulter counter. Cells were plated as single cells into 60-mm dishes in 5 ml of media, incubated for 6 h, and subsequently exposed to IR. The actual amounts of cells per dish were chosen to ensure that about 50 colonies would survive a particular radiation dose treatment. Cells were exposed to IR in the dose range of 0 to 8 Gy at room temperature. Cells were incubated for 12 or more days and were fixed in methanol:acetic acid (3:1) prior to staining with crystal violet. Only colonies containing >50 cells were counted.
Metaphase chromosome spreads were prepared by procedures described previously (35). Giemsa-stained chromosomes of metaphase spreads were analyzed for chromosome end-to-end associations. G1 phase-specific chromosomal aberrations were assessed as described previously (37). Briefly, cells in plateau phase were irradiated with 3 Gy, allowed to incubate for 24 h, and subcultured, and metaphases were collected. Chromosome spreads were prepared by the procedure described previously (35). The categories of G1-type asymmetrical chromosome aberrations scored included dicentrics, centric rings, interstitial deletions/acentric rings, and terminal deletions.
S-phase-specific chromosomal aberrations were analyzed at metaphase. Exponentially growing cells were treated with 2 Gy of gamma radiation, and mitotic cells were collected 3 to 6 h after irradiation. Both chromosome- as well as chromatid-type aberrations were scored. For G2 phase-specific chromosomal aberrations, cells in exponential phase were irradiated with 1 Gy, and metaphases were collected at 45 and 90 min following irradiation and examined for chromatid breaks and gaps per metaphase as described previously (33).
Neutral filter elution. The level of DNA DSBs in cells was estimated as described previously (40). Cells were labeled for a period of one-and-one-half doublings and then were washed free of radioactive medium and reincubated in nonradioactive medium for an additional 3 h prior to the experiment. Cells were exposed to IR and incubated at 37°C for different times postirradiation. Cells were layered onto polycarbonated filters, lysed, and eluted under neutral conditions (pH 9.6) as described previously (40). Relative elution (RE) was calculated as RE = log(FI/Fc), where FI and Fc are the fractions of DNA left on the filter for the irradiated (I) and unirradiated (c) cells when 75% of the internal standard DNA is left on the filter.
| RESULTS |
|---|
|
|
|---|
The interaction between hMOF and ATM was examined by liquid ß-gal assays (Fig. 1). Full-length hMOF and ATM fragments containing leucine zippers (LZ) exhibited 3.4- to 7.8-fold higher ß-gal activities than that observed for the empty vector control. Minimum interactions were found between ATM fragments containing the PI3-kinase domain and hMOF or between hMOF proteins. Deletion of the region containing the LZ domain of the ATM fragment or deletion of the region containing the chromodomain of hMOF resulted in a loss of interaction, establishing that the association of the two proteins occurs via the interaction of these regions containing the domains (Fig. 1).
To confirm that the interactions between ATM and hMOF occurred in mammalian cells, we performed coimmunoprecipitation (coIP) experiments. Anti-ATM antibody immunoprecipitated endogenous hMOF only from cells expressing functional ATM, and the association between the two proteins did not change after exposure to IR (Fig. 2A). The reciprocal immunoprecipitation yielded the same results (Fig. 2B). The association of hMOF and ATM was also confirmed in nonisogenic cells with respect to ATM function (data not shown).
|
LZ (ATM with a deletion of the LZ region) (10) and hMOF in ATM-deficient (AT221JE) cells and then examined for IR-induced ATM autophosphorylation. Deletion of the LZ region in ATM resulted in a loss of interaction with hMOF and also IR-induced ATM autophosphorylation (Fig. 3D). Such results are consistent with the fact that ATM
LZ retains kinase activity in vitro; however, it is unable to phosphorylate its substrates in vivo (10).
|
MOF; fragment 1 of Fig. 1A) or with hMOF knockdown were analyzed by Western blotting for IR-induced acetylation of histone H4 at K16. In comparison to the levels in the control, only cells expressing
hMOF (Fig. 1A) or cells with hMOF knockdown (Fig. 5C) had decreased acetylation of histone H4 at K16 after IR exposure (Fig. 5B, D), irrespective of the presence of ATM; cells overexpressing full-length hMOF (Fig. 5A) had higher levels of IR-induced K16 acetylation of histone H4 than control cells did (Fig. 5B). These results suggest that IR exposure enhances hMOF-dependent acetylation of histone H4 at K16 independently of ATM function.
|
|
hMOF abrogated ATM autophosphorylation in irradiated cells (Fig. 6A), whereas the expression of hMOF fragments 2 to 4 had little effect on ATM autophosphorylation (data not shown). To determine whether the hMOF association influences ATM autophosphorylation, cells expressing HA-tagged wild-type hMOF and
hMOF were irradiated and examined for ATM Ser1981 phosphorylation (Fig. 6B). Interestingly, ATM complexed with full-length hMOF displayed IR-induced ATM phosphorylation (Fig. 6Ba), whereas no such phosphorylation was observed in ATM associated with the
hMOF deletion mutant (Fig. 6Bb). The influence of hMOF on IR-induced ATM autophosphorylation is consistent with the influence of hMOF on ATM monomerization (Fig. 6C). Furthermore, cells expressing
hMOF or cells with hMOF knockdown also had greatly reduced IR-induced ATM kinase activity, as determined by an in vitro kinase assay (Fig. 6D) (41).
|
|
hMOF as well as cells with hMOF knockdown had reduced IR-induced phosphorylation of Chk2 at Thr-68 compared to control cells (Fig. 8). These results support the argument that hMOF function influences ATM-dependent phosphorylation of its downstream DNA damage response effectors.
|
hMOF is similar to that in cells with hMOF knockdown. In contrast, the overexpression of hMOF had no effect on the frequency of chromosome end associations. Since chromosome end-to-end associations may lead to anaphase bridge formation, the same cells were analyzed for anaphase bridges. Cells expressing the
hMOF and cells with hMOF knockdown displayed about threefold higher frequencies of anaphase bridges compared to parental cells (Table 1). Chromosome end associations and bridges can induce spontaneous chromosome as well as chromatid breaks. Cells expressing
hMOF and cells with hMOF knockdown displayed higher frequencies of chromatid as well as chromosome breaks when compared to parental cells (Table 1). Once again, no significant change in chromosomal break frequencies was observed in cells overexpressing wild-type hMOF (Table 1).
|
hMOF and cells with hMOF knockdown exhibited modest enhancements of cell killing in response to IR exposure compared to parental cells, while ATM/ cells expressing
hMOF did not (Fig. 9). However, cells overexpressing hMOF exhibited decreased IR sensitivity for cell killing (Fig. 9). Thus, cells expressing
hMOF and cells with hMOF knockdown display karyotypic instability and decreased cell survival after IR exposure. All of these cellular phenotypes could be linked with defective chromosomal repair, as has been reported for cells deficient for ATM (36).
|
hMOF according to the previously described procedure (45). Cells expressing
hMOF exhibited a significant increase in residual IR-induced G1 chromosomal aberrations seen at metaphases (Fig. 10A). To determine whether defective repair can be documented in cells expressing
hMOF in phases of the cell cycle other than G1, S-phase-specific chromosome aberrations in such cells were evaluated. Cells expressing
hMOF displayed higher frequencies of S-phase-specific chromatid and chromosomal aberrations per metaphase when compared to parental cells (Fig. 10B). Similar results were obtained when G2-phase-specific chromosome aberrations were evaluated (Fig. 10C). The overexpression of hMOF resulted in a modest, although not statistically significant, decrease in residual chromosome aberrations in all the three phases of the cell cycle (Fig. 10). In addition, we used a previously described biochemical approach (38) to determine the influence of hMOF on DNA DSB repair after IR exposure. As illustrated in Fig. 11, cells expressing
hMOF (fragment 1 in Fig. 1A) have higher amounts of residual DNA DSBs, and cells overexpressing hMOF have relatively less residual DNA DSBs, than control cells. The observation that the expression of
hMOF (fragment 1 in Fig. 1A) results in a higher frequency of chromosome aberrations irrespective of which cell cycle phase was analyzed supports the idea that the inactivation of hMOF reduces the cell's capacity for global DNA repair.
|
|
hMOF displayed neither a significant increase in G1 phase cells nor a decrease in S-phase entry after IR treatment compared to control cells that showed a significant decrease in S-phase entry, indicating G1 arrest (Fig. 12A). The loss of the G1 checkpoint seen in cells expressing
hMOF is similar to that in A-T cells (53), indicating that this phenotype is mimicked in cells expressing
hMOF. In addition to the G1 checkpoint, IR causes a transient inhibition of DNA replication. Cells deficient in ATM function exhibit radioresistant DNA synthesis, an indicator of the loss of the S-phase checkpoint. Cells expressing
hMOF showed decreased inhibition of DNA synthesis, compared to the parental cells, following IR exposure (Fig. 12B). A-T cells also show defective G2/M checkpoints after DNA damage, and ATM signaling has been shown to be required for the G2/M checkpoint in response to IR (54). The efficiency of G2 checkpoint control was evaluated by measuring the proportion of cells in mitosis (mitotic index) after IR exposure (11). Cells expressing
hMOF exhibited a decrease in mitotic index of approximately 25%, while the decrease in the parental control cells was approximately 68% (Fig. 12C). These results suggest that the inactivation of hMOF does lead to a defective G2 checkpoint.
|
| DISCUSSION |
|---|
|
|
|---|
The interaction of hMOF with ATM is substantiated by our coimmunoprecipitation data and by the fact that we were able to map their respective regions of interaction. Using RNA interference-mediated knockdown of hMOF and a cDNA encoding an hMOF protein that lacks the C-terminal end including the acetyl-CoA binding site, we have obtained evidence that hMOF function is necessary for ATM activation. This conclusion is based on the observation that hMOF inactivation reduces IR-induced autophosphorylation of ATM as well as its kinase activity, thereby bypassing cell cycle arrest and increasing the chromosome damage. It should be noted that although the overexpression of the
hMOF fragment may produce nonspecific effects that would complicate the interpretation of experimental results, in the numerous experiments where both RNA interference-mediated knockdown of hMOF and
hMOF were used, the results obtained with these two approaches were found to be very similar.
Like its ortholog in Drosophila, and in contrast to all other known histone acetyltransferases, hMOF acetylates histone H4 uniquely at lysine 16. In Drosophila, this particular isoform of H4 is restricted to the X chromosome in males, where its presence is directly correlated to the transcriptional enhancement responsible for dosage compensation (6). In humans, it is abundantly distributed throughout the euchromatic chromosome complement (21). This observation and the extent and rapidity with which ATM is phosphorylated and monomerized following IR exposure (4) would suggest a possibility of a link between H4 acetylation by hMOF and ATM activation.
However, TSA- or NaB-induced enhancement of acetylation levels of histone H4 at K16 has minimum influence on ATM kinase activity, suggesting that modifications in the component of chromatin are not sufficient for ATM activation. Such results are consistent with the fact that ATM activation is not dependent on such chromatin modifications alone, as ATM kinase activity before and after IR exposure of S phase is similar to that of G1- and G2/M-phase cells (41).
A more plausible explanation for the functional interaction of hMOF and ATM is the acetylation by hMOF of ATM itself or of an unknown nonhistone protein involved in ATM activation. Acetyltransferases that acetylate both histone and nonhistone proteins include p300, CBP, PCAF, and Tip60, which acetylates the androgen receptor in addition to H2A, H3, and H4 (55). More specifically, Drosophila MOF has been shown to acetylate MSL3 (male-specific lethal 3), another component of the dosage compensation MSL complex; the acetylation is required for specific MSL3 functions (7). Our observation that the level of H4K16-Ac is increased by exposure to IR without any apparent increase in the amount of hMOF or of its activity and irrespective of the presence of ATM can be explained by suggesting that DSBs induce a more relaxed chromatin topology, thereby increasing nucleosomal access. TSA-treated cells exhibited a very slight increase in ATM autophosphorylation without any change in ATM kinase activity in the absence of irradiation. The saturation of acetylation sites in the chromatin of these cells could free some hMOF, leading to some unscheduled acetylation of its nonhistone target(s). Whether ATM activation could be due to the acetylation by hMOF is not known at present. Our analysis revealed that hMOF does not influence the function of monomeric ATM in an in vitro assay (Fig. 7), supporting the argument that hMOF may act as a transducer of chromatin structural alterations to ATM after DNA damage.
However, the observation that hMOF-mediated chromatin alteration in response to IR exposure correlates with ATM activation supports the proposition that chromatin structure may represent the coupling mechanism between intermolecular ATM phosphorylation and IR-induced alterations in chromatin structure, as proposed by Bakkenist and Kastan (4). Consistent with the potential role of hMOF in ATM activation is the ability of dominant negative hMOF mutations or hMOF knockdown to recapitulate the cellular characteristics of A-T cells, especially in their response to exposure to IR. hMOF plays a role in signaling the DNA damage response, as evidenced by its influence on the phosphorylation of ATM downstream effectors. Subsequent to the acetylation of histone H4 at K16 should be deacetylation in order to put back the repaired DNA into nucleosomal form. It has been elegantly demonstrated that histone H4K16 is deacetylated at sites of DSBs in yeast (20), further supporting the argument that hMOF plays a role very early in DNA damage repair. Kim et al. (27) have shown that ATM interacts with the histone deacetylase HDAC1 both in vitro and in vivo and that the extent of this association is increased after the exposure of MRC5CV1 human fibroblasts to ionizing radiation. Consistent with our results for histone H4 K16 acetylation induced by IR, Ju and Miller (22) also found no differences in H3 and H4 histone acetylation among A-T and normal cells in response to histone deacetylase inhibitor treatments.
Despite the interaction of a fraction of hMOF with ATM, hMOF-mediated acetylation of histone H4 at K16 following IR exposure is independent of ATM function. In addition, the inactivation of hMOF enhances IR-induced cell killing only in ATM+/+ cells and not in ATM/ cells, suggesting that hMOF functions upstream of ATM. The results indicating that ATM autophosphorylation occurs only in ATM associated with wild-type hMOF but not with
hMOF support the argument that the association of functional hMOF with ATM is critical for IR-induced ATM activation. Hasan and Hottiger (14) proposed that in DNA repair, chromosomal repression is relieved by the acetylation of histone N-terminal lysine residues, similar to the loss of chromosomal repression that allows the successful transcription of the underlying genes. Since the acetylation of the tail domain of histone H4 at K16 links with DNA repair (5) and transcription (1), further experiments are required to determine how MOF-mediated modifications discriminate the signals induced by DNA damage and transcription.
| ACKNOWLEDGMENTS |
|---|
This investigation was supported by NIH (NS34746, CA10445 [project 2]), the Department of Army, the A-T Children's Society, and funds from Radiation Oncology, Washington University School of Medicine, to T.K.P. and NCI grant PO1 CA97403 (project 5) to T.L.
| FOOTNOTES |
|---|
Present address: Laboratory of Chromatin Biology, Rockefeller University, 1230 York Avenue, New York, NY 10021. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Allard, S., R. T. Utley, J. Savard, A. Clarke, P. Grant, C. J. Brandl, L. Pillus, J. L. Workman, and J. Cote. 1999. NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J. 18:5108-5119.[CrossRef][Medline]
3. Allfrey, V. G., B. G. Pogo, V. C. Littau, E. L. Gershey, and A. E. Mirsky. 1968. Histone acetylation in insect chromosomes. Science 159:314-316.
4. Bakkenist, C. J., and M. B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.[CrossRef][Medline]
5. Bird, A. W., D. Y. Yu, M. G. Pray-Grant, Q. Qiu, K. E. Harmon, P. C. Megee, P. A. Grant, M. M. Smith, and M. F. Christman. 2002. Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair. Nature 419:411-415.[CrossRef][Medline]
6. Bone, J. R., J. Lavender, R. Richman, M. J. Palmer, B. M. Turner, and M. I. Kuroda. 1994. Acetylated histone H4 on the male X chromosome is associated with dosage compensation in Drosophila. Genes Dev. 8:96-104.
7. Buscaino, A., T. Kocher, J. H. Kind, H. Holz, M. Taipale, K. Wagner, M. Wilm, and A. Akhtar. 2003. MOF-regulated acetylation of MSL-3 in the Drosophila dosage compensation complex. Mol. Cell 11:1265-1277.[CrossRef][Medline]
8. Carrozza, M. J., R. T. Utley, J. L. Workman, and J. Cote. 2003. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19:321-329.[CrossRef][Medline]
9. Carson, C. T., R. A. Schwartz, T. H. Stracker, C. E. Lilley, D. V. Lee, and M. D. Weitzman. 2003. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22:6610-6620.[CrossRef][Medline]
10. Chen, S., P. Paul, and B. D. Price. 2003. ATM's leucine-rich domain and adjacent sequences are essential for ATM to regulate the DNA damage response. Oncogene 22:6332-6339.[CrossRef][Medline]
11. Dhar, S., J. A. Squire, M. P. Hande, R. J. Wellinger, and T. K. Pandita. 2000. Inactivation of 14-3-3
influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol. Cell. Biol. 20:7764-7772.
12. Durfee, T., K. Becherer, P. L. Chen, S. H. Yeh, Y. Yang, A. E. Kilburn, W. H. Lee, and S. J. Elledge. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555-569.
13. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
14. Hasan, S., and M. O. Hottiger. 2002. Histone acetyl transferases: a role in DNA repair and DNA replication. J. Mol. Med. 80:463-474.[CrossRef][Medline]
15. Hilfiker, A., D. Hilfiker-Kleiner, A. Pannuti, and J. C. Lucchesi. 1997. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16:2054-2060.[CrossRef][Medline]
16. Hittelman, W. N., and T. K. Pandita. 1994. Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia. Int. J. Radiat. Biol. 66:S109-S113.[Medline]
17. Horejsi, Z., J. Falck, C. J. Bakkenist, M. B. Kastan, J. Lukas, and J. Bartek. 2004. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation. Oncogene 23:3122-3127.[CrossRef][Medline]
18. Hwang, K. K., and H. J. Worman. 2002. Gene regulation by human orthologs of Drosophila heterochromatin protein 1. Biochem. Biophys. Res. Commun. 293:1217-1222.[CrossRef][Medline]
19. Ikura, T., V. V. Ogryzko, M. Grigoriev, R. Groisman, J. Wang, M. Horikoshi, R. Scully, J. Qin, and Y. Nakatani. 2000. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102:463-473.[CrossRef][Medline]
20. Jazayeri, A., A. D. McAinsh, and S. P. Jackson. 2004. Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 101:1644-1649.
21. Jeppesen, P., and B. M. Turner. 1993. The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74:281-289.[CrossRef][Medline]
22. Ju, R., and M. T. Muller. 2003. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. Cancer Res. 63:2891-2897.
23. Karlseder, J., K. Hoke, O. K. Mirzoeva, C. Bakkenist, M. B. Kastan, J. H. Petrini, and T. de Lange. 2004. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2:E240. [Online.][CrossRef][Medline]
24. Khanna, K. K. 2000. Cancer risk and the ATM gene: a continuing debate. J. Natl. Cancer Inst. 92:795-802.
25. Khanna, K. K., and S. P. Jackson. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:247-254.[CrossRef][Medline]
26. Khanna, K. K., K. E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S. P. Lees-Miller, and M. F. Lavin. 1998. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20:398-400.[CrossRef][Medline]
27. Kim, G. D., Y. H. Choi, A. Dimtchev, S. J. Jeong, A. Dritschilo, and M. Jung. 1999. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J. Biol. Chem. 274:31127-31130.
28. Kusch, T., L. Florens, W. H. Macdonald, S. K. Swanson, R. L. Glaser, J. R. Yates III, S. M. Abmayr, M. P. Washburn, and J. L. Workman. 2004. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306:2084-2087.
29. Lee, J. H., and T. T. Paull. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304:93-96.
30. Lim, D. S., D. G. Kirsch, C. E. Canman, J. H. Ahn, Y. Ziv, L. S. Newman, R. B. Darnell, Y. Shiloh, and M. B. Kastan. 1998. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc. Natl. Acad. Sci. USA 95:10146-10151.
31. Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. J. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97:10389-10394.
32. McGowan, C. H. 2002. CHK2: a tumor suppressor or not? Cell Cycle 1:401-403.[Medline]
33. Morgan, S. E., C. Lovly, T. K. Pandita, Y. Shiloh, and M. B. Kastan. 1997. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17:2020-2029.[Abstract]
34. Neal, K. C., A. Pannuti, E. R. Smith, and J. C. Lucchesi. 2000. A new human member of the MYST family of histone acetyl transferases with high sequence similarity to Drosophila MOF. Biochim. Biophys. Acta 1490:170-174.[Medline]
35. Pandita, T. K. 1983. Effect of temperature variation on sister chromatid exchange frequency in cultured human lymphocytes. Hum. Genet. 63:189-190.[CrossRef][Medline]
36. Pandita, T. K. 2003. A multifaceted role for ATM in genome maintenance. Expert Rev. Mol. Med. 5:1-21.
37. Pandita, T. K., and C. R. Geard. 1996. Chromosome aberrations in human fibroblasts induced by monoenergetic neutrons. I. Relative biological effectiveness. Radiat. Res. 145:730-739.[Medline]
38. Pandita, T. K., and W. N. Hittelman. 1992. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat. Res. 131:214-223.[Medline]
39. Pandita, T. K., and W. N. Hittelman. 1995. Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int. J. Cancer 61:738-743.[Medline]
40. Pandita, T. K., and W. N. Hittelman. 1992. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130:94-103.[Medline]
41. Pandita, T. K., H. B. Lieberman, D. S. Lim, S. Dhar, W. Zheng, Y. Taya, and M. B. Kastan. 2000. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 19:1386-1391.[CrossRef][Medline]
42. Pandita, T. K., S. Pathak, and C. R. Geard. 1995. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. Cell Genet. 71:86-93.[Medline]
43. Shahrabani-Gargir, L., T. K. Pandita, and H. Werner. 2004. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. Endocrinology 145:5679-5687.
44. Sharma, G. G., A. Gupta, H. Wang, H. Scherthan, S. Dhar, V. Gandhi, G. Iliakis, J. W. Shay, C. S. Young, and T. K. Pandita. 2003. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22:131-146.[CrossRef][Medline]
45. Sharma, G. G., K. K. Hwang, R. K. Pandita, A. Gupta, S. Dhar, J. Parenteau, M. Agarwal, H. J. Worman, R. J. Wellinger, and T. K. Pandita. 2003. Human heterochromatin protein 1 isoforms HP1Hs
and HP1Hsß interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol. Cell. Biol. 23:8363-8376.
46. Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155-168.[CrossRef][Medline]
47. Smilenov, L. B., S. Dhar, and T. K. Pandita. 1999. Altered telomere nuclear matrix interactions and nucleosomal periodicity in ataxia telangiectasia cells before and after ionizing radiation treatment. Mol. Cell. Biol. 19:6963-6971.
48. Smilenov, L. B., W. Mellado, P. H. Rao, S. G. Sawant, C. B. Umbricht, S. Sukumar, and T. K. Pandita. 1998. Molecular cloning and chromosomal localization of Chinese hamster telomeric protein chTRF1. Its potential role in chromosomal instability. Oncogene 17:2137-2142.[CrossRef][Medline]
49. Smith, E. R., A. Pannuti, W. Gu, A. Steurnagel, R. G. Cook, C. D. Allis, and J. C. Lucchesi. 2000. The Drosophila MSL complex acetylates histone H4 at lysine 16, a chromatin modification linked to dosage compensation. Mol. Cell. Biol. 20:312-318.
50. Tse, C., T. Sera, A. P. Wolffe, and J. C. Hansen. 1998. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell. Biol. 18:4629-4638.
51. Turner, B. M., A. J. Birley, and J. Lavender. 1992. Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei. Cell 69:375-384.[CrossRef][Medline]
52. Uziel, T., Y. Lerenthal, L. Moyal, Y. Andegeko, L. Mittelman, and Y. Shiloh. 2003. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:5612-5621.[CrossRef][Medline]
53. Wood, L. D., T. L. Halvorsen, S. Dhar, J. A. Baur, R. K. Pandita, W. E. Wright, M. P. Hande, G. Calaf, T. K. Hei, F. Levine, J. W. Shay, J. J. Wang, and T. K. Pandita. 2001. Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene 20:278-288.[CrossRef][Medline]
54. Xu, B., S. T. Kim, D. S. Lim, and M. B. Kastan. 2002. Two molecularly distinct G2/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 22:1049-1059.
55. Yang, X. J. 2004. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32:959-976.
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||